Scientists in 12 American cities are beginning tests of an experimental vaccine that could protect people against anthrax, a rare disease that has become a potential bioterrorism agent.A vaccine for anthrax already is in use, mainly to protect military personnel, but it requires six shots over 18 months and an annual booster shot. The vaccine also causes a number of side effects.
